PKD2 and cholangiocarcinoma: In this study, lnc-PKD2-2-3 was confirmed to promote oncogenic and stem-like characteristics such as poor tumour differentiation, advanced TNM stage, increased carcinoembryonic antigen expression, and was associated with poor overall survival for cholangiocarcinoma patients.